Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of ciprofol + sufentanil for laryngeal mask insertion in young vs elderly adults
ChiCTR2400080891Phase 4Completed
- Sponsor
- Nanchong City Central Hospital
- Start
- Feb 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None (2 arms), sponsored by Nanchong City Central Hospital. Primary endpoint: ED50. Started Feb 2024; status: completed.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2400080891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080891.